Debbie Weir was named chief executive officer of the Cancer Support Community.
Jeffrey Peppercorn was appointed the next editor-in-chief of JCO Oncology Practice, an American Society of Clinical Oncology journal. Peppercorn will begin serving as editor designee of JCO OP on March 1, and as editor-in-chief on Sept. 1.
Jhanelle Gray was named chair of the SWOG Cancer Research Network’s Lung Cancer Committee, effective April 1.
B.J. Rimel, associate professor of obstetrics and gynecology at Cedars-Sinai Cancer at the Cedars-Sinai Medical Center, has been named medical director for the Cancer Clinical Trials Office.
Marie Wood was named medical director of the Cancer Clinical Trials Office at The University of Colorado Cancer Center.
Joshua Eaves was named senior vice president of corporate development at Florida Cancer Specialists and Research Institute.
City of Hope’s Department of Stem Cell Biology and Regenerative Medicine received a $4.9 million grant from the California Institute for Regenerative Medicine to train scientists in basic stem cell research and its clinical translation.
Ben Ho Park, Cornelius Abernathy Craig Professor of Medicine and deputy director of the Vanderbilt-Ingram Cancer Center, was named the center’s new director.
Ross Levine was named deputy physician-in-chief of translational research at Memorial Hospital, the main Manhattan hospital for Memorial Sloan Kettering Cancer Center.
The U.S, Senate Feb. 15 voted 50-46 to confirm Robert Califf as the next commissioner of FDA.
